{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:39:04Z","timestamp":1786736344775,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijp.ijp_743_17","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T04:13:27Z","timestamp":1574655207000},"page":"323","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of drug utilization in cardiovascular disease at a teaching and referral hospital in Northern Telangana"],"prefix":"10.4103","volume":"51","author":[{"given":"RaghuramRao","family":"Akkinepally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Naliganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekhar","family":"Valupadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivarani","family":"Eesam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.271643-1","unstructured":"Naliganti C, Valupadas C, Akkinepally RR. A study on rational use of medicines in cardiology unit of a teaching hospital. Poster presented in 68th Indian Pharmaceutical Congress- 2016, on December 16-18; Visakhapatnam, Andhra Pradesh, India (poster no. L012). This was awarded as the best poster."},{"key":"key-10.4103\/0253-7613.271643-2","unstructured":"World Health Organization. Non-Communicable Diseases Country Profiles. Geneva: World Health Organization; 2014. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/128038\/1\/9789241507509_eng.pdf. [Last accessed on 2014 Oct 24]."},{"key":"key-10.4103\/0253-7613.271643-3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(08)60623-6","article-title":"Treatment and outcomes of acute coronary syndromes in India (CREATE): A prospective analysis of registry data","author":"Xavier","year":"2008","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.271643-4","doi-asserted-by":"crossref","first-page":"e62061","DOI":"10.1371\/journal.pone.0062061","article-title":"Association between gender, process of care measures, and outcomes in ACS in India: Results from the detection and management of coronary heart disease (DEMAT) registry","author":"Pagidipati","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/0253-7613.271643-5","unstructured":"World Health Organization. How to Investigate Drug use in Health Facilities: Selected Drug Use Indicators. Geneva: World Health Organization; 1993; EDM Research Series 007. Available from: https:\/\/apps.who.int\/medicinedocs\/en\/d\/Js2289e\/. [Last accessed on 2014 Sep 18]."},{"key":"key-10.4103\/0253-7613.271643-6","unstructured":"World Health Organization. Introduction to Drug Utilization Research\/WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Geneva: World Health Organization; 2003. Available from: https:\/\/apps.who.int\/medicinedocs\/pdf\/s4876e\/s4876e.pdf. [Last accessed on 2014 Sep 18]."},{"key":"key-10.4103\/0253-7613.271643-7","first-page":"155","article-title":"Drug utilization study in patients of acute coronary syndrome on follow-upvisits at a tertiary care centre in Kolkata","author":"Abhishek","year":"2012","journal-title":"Asian J Pharm Life Sci"},{"key":"key-10.4103\/0253-7613.271643-8","first-page":"6","article-title":"A prospective study on drug utilization of cardiac unit in acute myocardial infarction of hospitalized patients","author":"Chandana","year":"2013","journal-title":"Int J Pharmacother"},{"key":"key-10.4103\/0253-7613.271643-9","first-page":"24","article-title":"Prescribing pattern in coronary artery disease: A prospective study","author":"Shruthi","year":"2014","journal-title":"Int J Pharm Res Rev"},{"key":"key-10.4103\/0253-7613.271643-10","first-page":"824","article-title":"Drug utilization study in intensive cardiac care unit of a tertiary care hospital","author":"Jyothi","year":"2015","journal-title":"Int J Pharm Res Health Sci"},{"key":"key-10.4103\/0253-7613.271643-11","first-page":"857","article-title":"Drug utilization study in congestive heart failure at a tertiary care hospital","author":"Prasaana","year":"2015","journal-title":"Sch J App Med Sci"},{"key":"key-10.4103\/0253-7613.271643-12","first-page":"463","article-title":"Drug utilization pattern in patients with congestive cardiac failure in a South Indian tertiary care hospital-a retrospective study","author":"Bharath","year":"2015","journal-title":"Int Res J Pharm"},{"key":"key-10.4103\/0253-7613.271643-13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/0976-500X.119717","article-title":"Cardiovascular medications among the critically ill patients of a tertiary care hospital: A drug utilization study","author":"John","year":"2013","journal-title":"J Pharmacol Pharmacother","ISSN":"https:\/\/id.crossref.org\/issn\/0976-500X","issn-type":"print"},{"key":"key-10.4103\/0253-7613.271643-14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1995.tb04402.x","article-title":"Promoting rational prescribing: An international perspective","author":"Hogerzeil","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.271643-15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2009.06.003","article-title":"The expanded global registry of acute coronary events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes","author":"Goodman","year":"2009","journal-title":"Am Heart J"},{"key":"key-10.4103\/0253-7613.271643-16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"The second euro heart survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean basin in 2004","author":"Mandelzweig","year":"2006","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0253-7613.271643-17","first-page":"161","article-title":"Treatment of acute myocardial infarction: Does the type of hospital make a difference.PPAMI study group?","author":"George","year":"1999","journal-title":"Indian Heart J"},{"key":"key-10.4103\/0253-7613.271643-18","first-page":"3150","article-title":"Does the Pharmacological management of unstable angina vary with age and gender \u2013 A descriptive study","author":"Banerjee","year":"2010","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/0253-7613.271643-19","unstructured":"Hirsh J, Warkenitin TE, Raschke R, Granger C, Ohman EM, Dale JE. Heparin & LMW heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 1998;114:4895-5105."},{"key":"key-10.4103\/0253-7613.271643-20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s002280000226","article-title":"A study of drug utilisation and cost of treatment in patients hospitalised with unstable angina","author":"Malhotra","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.271643-21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2004.11.055","article-title":"Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology\/American Heart Association guidelines) national quality improvement initiative","author":"Blomkalns","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0253-7613.271643-22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients.Excess length of stay, extra costs, and attributable mortality","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.271643-23","unstructured":"World Health Organization. Guidelines on the use of International Non-Proprietary Names (INNs) for Pharmaceutical Substances. Geneva: World Health Organization; 1997. Available from: http:\/\/apps.who.int\/medicinedocs\/en\/d\/Jh1806e\/. [Last accessed on 2014 Sep 24]."},{"key":"key-10.4103\/0253-7613.271643-24","unstructured":"World Health Organization. Antimicrobial resistance: Global Report on Surveillance. Geneva: World Health Organization; 2014. Available from: https:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/. [Last accessed on 2014 Sep 18]."},{"key":"key-10.4103\/0253-7613.271643-25","unstructured":"World Health Organization. The Use of Essential Drugs. Seventh Report of WHO Expert Committee (Including the Revised Model List of Essential Drugs). Geneva: World Health Organization; 1997. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/41938. [Last accessed on 2014 Sep 18]."}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:40:39Z","timestamp":1786732839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_743_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["271643"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_743_17","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}